Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency. (2020)

First Author: Løchen A
Attributed to:  MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-020-75691-5

PubMed Identifier: 33149149

Publication URI: http://europepmc.org/abstract/MED/33149149

Type: Journal Article/Review

Volume: 10

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322